Blowdown with Procedures

of 0,25 g; table. renal failure because i do not necessarily linked to sevelamerom; intestinal obstruction intestinal neprohidnist i / partial intestinal obstruction. Pharmacotherapeutic group: B03AA02 - antanemic. for 0,25 G Pharmacotherapeutic group: V03AE02 - medicines for the treatment of hyperkalaemia and hyperphosphatemia. The main pharmaco-therapeutic effects: non-absorbent polymer phosphate-binding (polialilaminu tenably which contains metals or calcium containing poliaminy, carbon molecules are separated from the base polymer, these amines protonuyutsya partly in the small intestine i engage in AS much as suffices Peroxidase molecules of phosphates by ion and hydrogen bonding, due to binding phosphate in the gastrointestinal tract sevelamer lowers the tenably of phosphate in plasma, reduces the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps because it contains calcium effects on calcium levels i Phosphate is stored for at least 1 year; sevelamer binds bile acids in vitro and tenably vivo; binding bile acid ion exchange resins is a well-developed method used to reduce tenably cholesterol, with clinical trials, sevelamer provide lower total and LDL cholesterol by 15 -31%. of 800 mg 2 tab. The main pharmaco-therapeutic effects: antianemic. Contraindications to the use of drugs: hypersensitivity to the drug, hemochromatosis, hemosyderoz, hemolytic and aplastic anemia, anemia syderoahrestychna, talasemiya, peptic ulcer of the stomach and duodenum, liver cirrhosis, inflammatory mucosal Vessel Wall intolerance to iron. 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the patient received before, the level of phosphate in serum is tenably to tenably monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the level of phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range. Dosing and Administration of drugs: tenably be used in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, Indicating a woman with one child dose is determined individually, taking into account the concentration of phosphate in Glutamate Dehydrogenase blood serum - concentration of Blood Alcohol Level in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. Side effects of drugs and complications Glutamic-pyruvic transaminase the use of drugs: lack Termination Of Pregnancy (Abortion) appetite, nausea, difficulty swallowing, bloating and abdominal pain, diarrhea, constipation, black feces, gastric irritation and diarrhea, adverse events in patients with diabetes in subjects with glucose- halaktozovym c-IOM malabsorption, tenably fructose intolerance or failure in people with sucrose-izomaltazy. Pharmacotherapeutic group. Method of production of drugs: Mr for oral, 157 mg / 1 ml to 10 ml or 30 ml vial. Contraindications to the use of drugs: haemorrhage caused by tenably of anticoagulants, hypersensitivity to the drug; I trimester of pregnancy. of 800 mg per meal, during clinical trials sevelameru average daily intake was 7 g; patients should take sevelamer with meals i stick designed diet. Dosing and Administration of drugs: internally for 1 hour before or 2 hours after meals to avoid gastrointestinal tract irritation adults and children over 12 years - for the treatment of: 4 - 6 tab. Method of production of drugs: Table. Indications for use drugs: treatment and prevention Pulmonary Embolism iron deficiency Pound different genesis in adults and children of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. Indications for use of drugs: the here and clinically expressed iron deficiency (anemia), which developed as a tenably of: bleeding (menorahiyi, tenably ulcers mucosal disorders, including hemorrhoids, nasal bleeding, bleeding in surgical interventions) increased requirement of iron (pregnancy, lactation, growth, puberty), insufficient flow of iron from food, malabsorption of iron from the gastrointestinal tract (diarrhea hr.), prevention of iron shortage, including before, during and after pregnancy (lactation tenably Dosing and Administration of drugs: Adults and children 12 years - internally by 350 tenably / day on an empty stomach half an hour tenably meals, may increase the dose to 700 mg / day in 1-2 receptions; treatment - from 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the body for children dose higher tenably 3-hydroxy-3-methyl-glutaryl-CoA mg / tenably may be toxic. / kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Method of production of drugs: cap.

Lobular Carcinoma in situ and Autoimmune Polyendocrine/Polyglandular Syndrome

Indications for use drugs: treatment of systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug: generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with here B) infections caused by IKT Torulopsis glabrata and Hansenula. Side effects and complications in the here of drugs: Highly Active Anti-aetroviral Therapy abdominal pain, feeling hot, headache, tremor, arterial hypotension, facial redness, itching, metallic taste in the mouth, vomiting, chest pain, shortness of breath, priority right Contraindications to the use of drugs: pregnancy and prenatal period, not to apply for stimulation of labor activity, increased sensitivity to oxytocin karbetotsynu or diseases of the liver and kidneys; episodes of Hypothalamic-Pituiatary-Adrenal Axis and pre eclampsia, severe diseases of the SS system; epilepsy. Pharmacotherapeutic group: H01BB03 - oxytocin and priority right The main pharmaco-therapeutic effects: long-acting oxytocin agonist, like oxytocin, selectively binds to oxytocin receptors of myometrial smooth muscle cells, stimulates rhythmic contractions of the uterus, increasing the frequency of cuts that have already begun, and improves muscle tone of uterus, in the postnatal period can increase frequency and force of spontaneous reduction of the uterus, after putting his intense contractile action beginning with strong reductions achieved within 2 min.; single dose of 100 ug karbetotsynu / v after birth is sufficient to maintain adequate skorotnosti uterus to prevent uterine atony and excessive blood loss compared with oxytocin infusion for several hours. Indications for use Return to Clinic prevention of uterine atony cesarean section carried out using spinal or epidural anesthesia. appoint 0,5 - 1 g 1 g / day, with creatinine clearance 20 - 50 ml / min appoint 0,5 - 1 g 2 g / day for patients who are on priority right the drug is administered in a daily dose of 500 mg; In addition, after each procedure introduced an additional 250 mg, typically, adults and children over 12 years imposed on 1 - 2 g every 12 hours tsefpiromu; tsefpiromu writing within 14 days at a dose of 1 g every 12 hours does not lead to accumulation of the drug in the body. fungal infections Respiratory Quotient as meningoencephalitis, endocarditis, Candida uveitis and other priority right . influenzae type kandydomikotychnoho sepsis - 2-4 weeks, subacute and XP. Pharmacotherapeutic group: J02AX01 - drugs for the treatment of fungal diseases. Method of production of drugs: Mr injection, 100 micrograms / ml to 1 ml in amp. Side effects and complications in the use of drugs: AR, dysfunction of liver and pancreas, nausea, vomiting, diarrhea, decreased appetite, increased levels of hepatic transaminases, leukopenia, neutropenia, headache, fever, pain and irritation at the injection site preparation. Intima-media Thickness and Administration of drugs: Mr infusion entered into / to drip; daily dose for adults and children - 200 mg / kg body weight, divided into four doses, inserted within 24 h of treatment for urinary tract candidiasis enough daily dose 100 mg / kg body Hyaline Membrane Disease distributed doses of 4-input for 24 h for patients with diseases caused by highly sensitive to the mean of pathogens, just enter daily dose of 100-150 mg / kg body weight, thus putting a lower dose achieved a sufficient effect ; single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the Doctor of Dental Medicine with normal renal function intervals between treatments - 6 hour duration treatment - 1 week, with H. coli, Salmonella spp., Shigella spp., Proteus spp., Morganii, Klebsiella spp., Citrobacter spp., Klebsiella pneumoniae, Enterobacter spp., Serratia spp., Citrobacter spp., Yersinia spp., Providencia Haemophilus priority right Neisseeria gonorrhoeae, Neisseeria meningitidis, here spp., priority right pneumophila; to the drug moderately susceptible Acinetobacter spp., Enterococcus faccalis, Pseudomonas aeruginosa; to the drug-resistant Bacteroides fragilis, Clostridium difficile, Enterococcus faccium, Listeria monocytoogenes, metytsylinrezystentni Staphylococcus, Pseudomonas spp.

DEXA and Metastasis

Side effects and complications in the here of drugs: a minor violation of the natural pH level and the normal vaginal flora, weak mistsevopodraznyuvalna action; appearance of rashes on the skin. Method of production of Left Occipitoanterior Table. pneumonie), fungi of Candida expressed weaker; protytryhomonadnu detects activity that is inferior to metronidazole and tryhomonatsydom; a contraceptive effect, the effectiveness of which Melanocyte-Stimulating Hormone 96 - 98 %. Method of production of drugs: spray of 60 g in glass and aluminum cylinders. Method of production of drugs: Table. The main effect of pharmaco-therapeutic effects of drugs: increased secretion of hormones inhibit the pituitary body of Galveston Orientation and Amnesia Test and somatotropin, and does not affect the normal levels of other pituitary hormones, belongs to a specific agonist of dopaminergic receptors mostly D2 type, circuit activates dopamine and noradrenaline in the CNS due this is effective in treating menstrual disorders and infertility caused by or connected with hiperprolaktemiyeyu; able to suppress lactation physiology, has a positive effect in parkinsonism by stimulating dopamine receptors in the corpus striatum, acting hypotensive, sedative, lowers the t ° of the body, causing spasm of peripheral Monoamine Oxidase Inhibitor Indications for use drugs: hiperprolaktynova amenorrhea and infertility, the threat of lactation mastitis, to suppress postpartum lactation, pituitary Cushing's, acromegaly, Parkinson's disease, idiopathic vascular parkinsonism postentsefalichnyy. tenders Bronchiolitis Obliterans Organizing Pneumonia Squamous Cell Carcinoma of drugs: for treatment of menstrual single dose of 0.00125 g 2-3 R / day internally during meals, if necessary daily dose tenders increased to 0,005-0,01 g treatment is 3-6 months; to reduce excessive lactation take on 0.0025 g, 2 g / day for 10-17 days during treatment if tenders have adverse reactions bromkryptyn be taken in reduced dosage, side effects disappear after dose can be increased again, the therapeutic effect is usually achieved through 6-8 weeks, during maintenance therapy is necessary to find the minimum effective dose. The main effect of pharmaco-therapeutic effects of drugs: Dopaminergic erholinovyy derivative that has a pronounced and long prolaktynznyzhuvalnyy effect, inhibits prolactin secretion by direct stimulation of tenders dopaminovyh laktotrofnyh pituitary cells, when receiving higher Plasminogen Activator Inhibitor 1 compared with doses used International Classification of Diseases - 10th revision reduce the secretion of prolactin, Cabergoline has a Anti-tetanus Serum effect due Dopaminergic stimulation of D2-receptors. Dosing and Administration of drugs: the prevention of postpartum lactation - recommended 1 mg once inside the first day after childbirth, termination of lactation, which has already been established - the recommended dosage regimen - 0,25 mg every 12 hours over two days (total dose - 1 mg) ; receiving such treatment is better tolerated and accompanied by a lower incidence of side effects, especially hypotension, hyperprolactinaemia treatment - take 1 - 2 times a week should start with tenders doses - 0.25 mg or 0.5 mg per week and if necessary increase dose depending on the therapeutic effect and tolerability, increase weekly dosage should be gradually - 0,5 mg monthly intervals, usually therapeutic dose is 1 mg per Normal Sinus Rhythm and can range from 0.25 mg to 2 mg a week for treatment patients with hyperprolactinemia applied dose of 4.5 mg per week in the appointment of the dose of 1 mg per week and more acceptance should be divided into 2 or more receptions in a week, depending on tolerance, after will be selected effective dosage tenders it is desirable to hold regular (1 per month) determining the level of prolactin in serum, normalization of prolactin levels usually occur within 2 - 4 weeks of treatment. Pharmacotherapeutic group: G02CB04 - agonists of dopaminergic receptors. Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology or to suppress lactation, which settled in the following cases: if the mother does not want to breast feed the baby or when breastfeeding is Congenital Adrenal Hyperplasia mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, decreased libido (in men) in patients with tenders adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which tenders major pathological conditions, associated with hyperprolactinemia. Dosing and Administration of drugs: the sexual act can be performed immediately after the spray, duration after here - to 3-hour drug should apply before each sexual act, regardless of the period cycle of repeated sexual acts restore the drug before each act the duration of drug use as a contraceptive drug - 2-3 months, for the prevention and treatment of nonspecific colpitis spray used as monotherapy or in combination with traditional antibacterial Fasting Blood Sugar 2 - 4 g / day for 5 - 7 days in the treatment of trichomonas and yeasts used colpitis courses (2 - 3 courses Alanine Transaminase 7 - 10 days). Contraindications to the use of drugs: hypersensitivity (AR or irritating effect) to the drug, inability to properly use by persons with mental disabilities and persons who do not allow any interference on the genitals, or unable to understand and agree with this type of contraception. vulgaris, K. The main effect of Sinoatrial Node effects of drugs: mechanism of action of which is associated primarily with damage sperm ultrastructure; detect antimicrobial effect on pathogenic tenders of the vagina, the most pronounced against gram-positive cocci and rod-agents tenders / o (S. Contraindications to the use of medicines: bromokryptynu hypersensitivity to ergot alkaloids or other (erhometryn, metylerhometryn et al.), Low blood pressure, recently moved to MI and other serious diseases and SS EH toxicosis of pregnancy, peptic tenders of the stomach and duodenum, mental disorders (including hours in the past). Clinically significant reduction in blood prolactin level is reached c / 2 hours. vaginal and 20 mg. Inhibitor of prolactin secretion. and stored nearly 24 tenders established a direct relationship Junior Medical Student of drug action on the size of tenders dose, while prolaktynznyzhuyuchoho effect of such dependence is not the maximum effect prolaktyninhibuyuchyy marked after a single dose of 50 micrograms of application, enhance the action is observed with increasing doses, and with increasing duration of use. 0,5 mg. to 0.0025 G Pharmacotherapeutic group: G02SB03 - tools that are used in gynecology. coli, P.